Citadel Advisors’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.9K Buy
+16,402
New +$91.4K ﹤0.01% 13177
2025
Q4
– Sell
-4,083
Closed -$1.74M – 14680
2025
Q3
$1.74M Buy
+4,083
New +$1.44M ﹤0.01% 6367

Other funds holding PMI

Citadel Advisors's PMI Position: Q3 2026 in Review

Citadel Advisors opened a new position in Picard Medical (PMI) in Q3 2026: 16,402 shares worth $68.9K. The stake represents ﹤0.01% of the portfolio and ranks #13177 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PMI as recently as Q3 2025.

Citadel Advisors first reported a position in PMI in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.74M in Q3 2025. 18 funds tracked by Wall St. Rank hold PMI as of Q3 2026.

  • Citadel Advisors held 16,402 shares of Picard Medical worth $68.9K as of Q3 2026.
  • Picard Medical was a new Citadel Advisors position in Q3 2026.
  • Picard Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13177 holding.
  • Citadel Advisors first reported a position in Picard Medical in Q3 2025 and has held it in 2 quarters since.
  • Citadel Advisors's Picard Medical position peaked at $1.74M in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Picard Medical as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.